CIBC Bancorp USA’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
CIBC Bancorp USA's CGON Position: Q3 2026 in Review
CIBC Bancorp USA increased its CG Oncology (CGON) stake by 79% in Q3 2026, buying an estimated $237K and bringing the position to 7,296 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #1306.
CIBC Bancorp USA first reported a position in CGON in Q3 2025 and has held it in 4 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q3 2026.
- CIBC Bancorp USA held 7,296 shares of CG Oncology worth $558K as of Q3 2026.
- CIBC Bancorp USA bought 3,222 CG Oncology shares in Q3 2026, an estimated $237K.
- CG Oncology made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1306 holding.
- CIBC Bancorp USA first reported a position in CG Oncology in Q3 2025 and has held it in 4 quarters since.
- 233 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.